153 related articles for article (PubMed ID: 38454739)
1. Loop diuretic down-titration at discharge in patients hospitalized for acute heart failure.
Croset F; Llàcer P; Núñez J; Campos J; García M; Pérez A; Fernández C; Fabregate M; López G; Tello S; Fernández JM; Ruiz R; Manzano L
ESC Heart Fail; 2024 Jun; 11(3):1739-1747. PubMed ID: 38454739
[TBL] [Abstract][Full Text] [Related]
2. Loop diuretic down-titration in stable chronic heart failure is often achievable, especially when urinary chloride concentration is low.
Verbrugge FH; Martens P; Boonen L; Nijst P; Verhaert D; Noyens P; De Vusser P; Dupont M; Tang WHW; Mullens W
Acta Cardiol; 2018 Aug; 73(4):335-341. PubMed ID: 28971753
[TBL] [Abstract][Full Text] [Related]
3. Intravenous Diuretic Therapy for the Management of Heart Failure and Volume Overload in a Multidisciplinary Outpatient Unit.
Buckley LF; Carter DM; Matta L; Cheng JW; Stevens C; Belenkiy RM; Burpee LJ; Young MA; Weiffenbach CS; Smallwood JA; Stevenson LW; Desai AS
JACC Heart Fail; 2016 Jan; 4(1):1-8. PubMed ID: 26656139
[TBL] [Abstract][Full Text] [Related]
4. In-Hospital Diuretic Agent Use and Post-Discharge Clinical Outcomes in Patients Hospitalized for Worsening Heart Failure: Insights From the EVEREST Trial.
Mecklai A; Subačius H; Konstam MA; Gheorghiade M; Butler J; Ambrosy AP; Katz SD
JACC Heart Fail; 2016 Jul; 4(7):580-588. PubMed ID: 27039131
[TBL] [Abstract][Full Text] [Related]
5. Determinants of Diuretic Responsiveness and Associated Outcomes During Acute Heart Failure Hospitalization: An Analysis From the NHLBI Heart Failure Network Clinical Trials.
Kiernan MS; Stevens SR; Tang WHW; Butler J; Anstrom KJ; Birati EY; Grodin JL; Gupta D; Margulies KB; LaRue S; Dávila-Román VG; Hernandez AF; de Las Fuentes L;
J Card Fail; 2018 Jul; 24(7):428-438. PubMed ID: 29482026
[TBL] [Abstract][Full Text] [Related]
6. Diuretic use and outcomes in patients with heart failure with reduced ejection fraction: Insights from the VICTORIA trial.
Ezekowitz J; Alemayehu W; Edelmann F; Ponikowski P; Lam CSP; O'Connor CM; Butler J; Corda S; McMullan CJ; Westerhout CM; Voors AA; Mentz RJ; Armstrong PW;
Eur J Heart Fail; 2024 Mar; 26(3):628-637. PubMed ID: 38450878
[TBL] [Abstract][Full Text] [Related]
7. Changes in Loop Diuretic Dose and Outcome After Cardiac Resynchronization Therapy in Patients With Heart Failure and Reduced Left Ventricular Ejection Fractions.
Martens P; Verbrugge FH; Nijst P; Dupont M; Mullens W
Am J Cardiol; 2017 Jul; 120(2):267-273. PubMed ID: 28532770
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Discharged Loop Diuretic Dose to Home Dose on Hospital Readmissions in Patients with Acute Decompensated Heart Failure: A Retrospective Cohort Study.
Alshibani M; Alshehri S; Alyazidi W; Alnomani A; Almatruk Z; Almeleebia T
Heart Surg Forum; 2020 Jul; 23(4):E470-E474. PubMed ID: 32726210
[TBL] [Abstract][Full Text] [Related]
9. Differential mortality association of loop diuretic dosage according to blood urea nitrogen and carbohydrate antigen 125 following a hospitalization for acute heart failure.
Núñez J; Núñez E; Miñana G; Bodí V; Fonarow GC; Bertomeu-González V; Palau P; Merlos P; Ventura S; Chorro FJ; Llàcer P; Sanchis J
Eur J Heart Fail; 2012 Sep; 14(9):974-84. PubMed ID: 22700856
[TBL] [Abstract][Full Text] [Related]
10. Outcomes Associated With a Strategy of Adjuvant Metolazone or High-Dose Loop Diuretics in Acute Decompensated Heart Failure: A Propensity Analysis.
Brisco-Bacik MA; Ter Maaten JM; Houser SR; Vedage NA; Rao V; Ahmad T; Wilson FP; Testani JM
J Am Heart Assoc; 2018 Sep; 7(18):e009149. PubMed ID: 30371181
[TBL] [Abstract][Full Text] [Related]
11. Intensification of pharmacological decongestion but not the actual daily loop diuretic dose predicts worse chronic heart failure outcome: insights from TIME-CHF.
Simonavičius J; Maeder MT; Eurlings CGMJ; Aizpurua AB; Čelutkienė J; Barysienė J; Toggweiler S; Kaufmann BA; Brunner-La Rocca HP
Clin Res Cardiol; 2021 Aug; 110(8):1221-1233. PubMed ID: 33216179
[TBL] [Abstract][Full Text] [Related]
12. Design and baseline characteristics of SALT-HF trial: hypertonic saline therapy in ambulatory heart failure.
Cobo Marcos M; Comín-Colet J; de la Espriella R; Rubio Gracia J; Morales-Rull JL; Zegrí I; Llacer P; Diez-Villanueva P; Jiménez-Marrero S; de Juan Bagudá J; Ortiz Cortés C; Goirigolzarri-Artaza J; García-Pinilla JM; Barrios E; Del Prado Díaz S; Montero Hernández E; Sanchez-Marteles M; Nuñez J
ESC Heart Fail; 2024 Jun; 11(3):1767-1776. PubMed ID: 38380837
[TBL] [Abstract][Full Text] [Related]
13. The association between high-dose loop diuretic use at discharge and cardiovascular mortality in patients with heart failure.
Okabe T; Yakushiji T; Kido T; Oyama Y; Igawa W; Ono M; Ebara S; Yamashita K; Yamamoto MH; Saito S; Amemiya K; Isomura N; Ochiai M
ESC Heart Fail; 2018 Feb; 5(1):87-94. PubMed ID: 28967699
[TBL] [Abstract][Full Text] [Related]
14. Rationale and study design of intravenous loop diuretic administration in acute heart failure: DIUR-AHF.
Palazzuoli A; Ruocco G; Vescovo G; Valle R; Di Somma S; Nuti R
ESC Heart Fail; 2017 Nov; 4(4):479-486. PubMed ID: 28980452
[TBL] [Abstract][Full Text] [Related]
15. Loop diuretic dose adjustments after a hospitalization for heart failure: insights from ASCEND-HF.
DeVore AD; Hasselblad V; Mentz RJ; O'Connor CM; Armstrong PW; McMurray JJ; Ezekowitz JA; Tang WH; Starling RC; Voors AA; Califf RM; Hernandez AF
Eur J Heart Fail; 2015 Mar; 17(3):340-6. PubMed ID: 25619549
[TBL] [Abstract][Full Text] [Related]
16. Higher doses of loop diuretics limit uptitration of angiotensin-converting enzyme inhibitors in patients with heart failure and reduced ejection fraction.
Ter Maaten JM; Martens P; Damman K; Dickstein K; Ponikowski P; Lang CC; Ng LL; Anker SD; Samani NJ; Filippatos G; Cleland JG; Zannad F; Hillege HL; van Veldhuisen DJ; Metra M; Voors AA; Mullens W
Clin Res Cardiol; 2020 Aug; 109(8):1048-1059. PubMed ID: 32002631
[TBL] [Abstract][Full Text] [Related]
17. Effect of admission oral diuretic dose on response to continuous versus bolus intravenous diuretics in acute heart failure: an analysis from diuretic optimization strategies in acute heart failure.
Shah RV; McNulty S; O'Connor CM; Felker GM; Braunwald E; Givertz MM
Am Heart J; 2012 Dec; 164(6):862-8. PubMed ID: 23194486
[TBL] [Abstract][Full Text] [Related]
18. Diuretic therapy as prognostic enrichment factor for clinical trials in patients with heart failure with reduced ejection fraction.
Coiro S; Girerd N; McMurray JJV; Pitt B; Swedberg K; van Veldhuisen DJ; Lamiral Z; Rossignol P; Zannad F
Clin Res Cardiol; 2021 Aug; 110(8):1308-1320. PubMed ID: 33956209
[TBL] [Abstract][Full Text] [Related]
19. Discharge Diuretic Dose and 30-Day Readmission Rate in Acute Decompensated Heart Failure.
Woodruff AE; Kelley AM; Hempel CA; Loeffler WJ; Echtenkamp CA; Hassan AK
Ann Pharmacother; 2016 Jun; 50(6):437-45. PubMed ID: 26956954
[TBL] [Abstract][Full Text] [Related]
20. Lung ultrasound and diuretic therapy in chronic heart failure: a randomised trial.
Cruz M; Ferreira JP; Diaz SO; Ferrão D; Ferreira AI; Girerd N; Sampaio F; Pimenta J
Clin Res Cardiol; 2024 Mar; 113(3):425-432. PubMed ID: 37289237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
